,title,time,label,ChangeK
0,"<특징주> 종목명, 사흘째 급등",2016-11-14 09:11:22,0.08668730650154788,-0.0050543630801107575
1,"종목명, 3000억규모 공급계약에 강세",2016-11-17 10:20:04,-0.014705882352941124,0.00045463844067827885
2,"[특징주] 종목명, 상승세..전거일 대비 1.19%↑",2016-11-21 11:27:06,0.005952380952380931,-0.00431985900296461
3,"<특징주> 종목명, 자회사 증자 참여 소식에 약세(종합)",2016-11-23 17:19:12,-0.06325301204819278,-0.00839555391804736
4,종목명 석연찮은 상장 ‘의혹’,2016-11-29 07:36:54,-0.02786377708978327,0.00013144232145645418
5,"종목명 ""상장 특혜설 억울하다""",2016-12-01 21:19:52,-0.01730103806228378,-0.006623826086956441
6,"이재용, 종목명 상장 특혜 의혹 일축",2016-12-06 18:00:33,0.03082191780821919,0.0010201873575541587
7,"종목명, 삼성바이오에피스 지분 800만주 추가 취득",2016-12-13 17:11:04,-0.013745704467353903,0.0004371432964680455
8,"[인베스트조선] 종목명 상장 한달, 우리사주 '좋다 말았네'",2016-12-16 07:03:03,0.01403508771929829,0.0027446865853866242
9,종목명·셀트리온 동반 강세,2016-12-28 18:35:27,-0.006578947368421018,0.0009730702595374119
10,"종목명, 의약품 위탁생산 1위 넘본다",2017-01-04 04:10:03,-0.022151898734177222,0.0008170589703835329
11,"종목명, ""2017년 시장 패러다임 변화 선도""",2017-01-13 18:25:03,-0.009803921568627416,-0.006076741877131031
12,"종목명, 오는 24일 결산실적 공시 예정",2017-01-18 16:23:02,-0.0032679738562091387,0.0010866730213470177
13,"종목명, 스위스 로슈와 86억원 규모 의약품 생산계약",2017-01-25 18:51:08,0.03870967741935494,0.008055457572678337
14,"종목명, 올 영업흑자 예상…목표가↑-유진",2017-01-31 08:04:01,0.0,-0.007688662032068527
15,"[종목플러스]종목명, 실적 확인 후 '고공비행'",2017-02-02 15:09:02,0.0521472392638036,-0.00455181981611763
16,"삼성그룹 ""종목명 상장 특혜 사실무근""",2017-02-10 11:49:57,-0.018633540372670843,0.004453402676364515
17,이재용 옭아맨 ‘종목명 논란’ 두 쟁점,2017-02-20 03:37:02,0.0031152647975076775,0.0018311311543761644
18,"금감원, 종목명 의혹 감리 검토",2017-02-21 15:39:03,-0.0030211480362537513,0.001750022644121163
19,"[사진]종목명, 최우수 IB기업 수상",2017-02-23 16:08:02,-0.014880952380952328,-0.00640993283923752
20,"[특징주]종목명, 휴미라 특허 무효소송 승소에 ↑",2017-03-06 11:19:00,0.015432098765432167,0.001255613710162251
21,"종목명 5거래일 연속 상승세, 이틀연속 신고가 행진",2017-03-21 10:27:06,0.029333333333333433,0.009907173773384681
22,"종목명, 바이오 대장주 꿰차고 쑥쑥",2017-03-22 11:13:44,-0.025906735751295318,-0.00462721588583459
23,"종목명, 'CMO리더십' 4회 연속 수상",2017-03-23 11:10:25,-0.005319148936170248,0.0020384272933251513
24,"[주총]김태한 종목명 대표, 세번째 연임 성공",2017-03-24 12:00:35,0.002673796791443861,-0.0017351614797671555
25,[여의도Talk] 종목명 “대장주는 나요 나~”,2017-03-27 14:26:01,-0.029333333333333322,-0.006127406948174374
26,"금감원, '분식논란' 종목명 특별감리(종합)",2017-03-30 08:44:26,-0.03542234332425065,-0.0010798839959749174
27,종목명 글로벌 진출 급제동,2017-03-31 05:31:02,-0.02259887005649719,-0.0020372501746183103
28,"종목명 특별 감리, 엇갈린 두 시선",2017-04-03 11:51:10,0.01734104046242768,0.0033700254451611844
29,"금감원, 종목명 등 올해 172곳 회계감리",2017-04-04 12:01:03,0.008522727272727293,-0.0029572698490099025
30,"[Hot-Line] 종목명, 불성실공시법인 지정 소식에 약세",2017-04-06 09:45:02,-0.005494505494505475,-0.003748570068556334
31,"종목명 김태한 사장, 자사주 1만5000주 매입",2017-04-10 16:33:29,0.020172910662824117,-0.00443907604022975
32,종목명 금감원 감리에 시끌시끌 “기업가치 뻥튀기” vs “국제기준 따랐을 뿐”,2017-04-17 09:29:04,0.011173184357541999,0.00509636494616772
33,"종목명, 1분기 실적 25일 발표",2017-04-19 15:56:04,-0.0027173913043477826,0.005027123313064985
34,"종목명, SB2 미국 최종 판매허가 획득",2017-04-24 08:08:18,-0.021390374331550777,0.004018378802831846
35,종목명 첫 흑자,2017-04-25 19:59:03,-0.016304347826086918,0.005002612608846269
36,"종목명 등 42개사, 5월 의무보호예수 해제",2017-04-28 09:43:51,-0.03581267217630857,-0.0018194581802607468
37,"종목명, 올들어 22% 주가 껑충...의약품 업종 견인",2017-05-01 06:01:22,0.02285714285714291,0.006452218777514229
38,"[Cover Story] 종목명, 글로벌 `넘버원` 바이오의약품 생산기업 목표",2017-05-10 04:08:05,-0.019073569482288777,-0.009874514951959568
39,종목명 등 10종목 코스피200 신규 편입,2017-05-17 15:52:23,0.010582010582010692,-0.0027299569954224445
40,"[특징주]종목명, 코스피200지수 편입 앞두고 강세",2017-05-19 15:19:31,0.007853403141361293,0.0007258603434645572
41,"송도 인근, 인천 새로운 블루칩…종목명 3공장 배후수요 `인천 논현포레`",2017-05-22 12:14:06,0.0025974025974024872,0.0067949246381433515
42,"날개 단 종목명, 20만원 넘었다",2017-05-25 11:12:43,0.020000000000000018,0.011042765855781456
43,"[특징주] 종목명, 사흘째 최고가 행진",2017-06-02 09:15:39,0.01091703056768556,0.01156263206366881
44,"[특징주]종목명, '외인 사자'에 3%↑",2017-06-07 14:43:03,0.053763440860215006,-0.0035802381053575694
45,[특징주] 종목명 엿새째 상승…또 신고가,2017-06-08 09:13:47,-0.038775510204081653,0.0014533778316165868
46,"[특징주]종목명, 외인 매수에 5%↑",2017-06-13 14:07:23,0.07221006564551424,0.007137727340729594
47,"종목명, 바이오 USA 참석",2017-06-20 11:29:26,-0.027027027027026973,-0.0007043409966787095
48,"김태한 사장 ""종목명, 수탁개발로 사업확장""(종합)",2017-06-21 11:05:28,-0.004273504273504258,-0.004938292651522236
49,"[특징주] 종목명, '임랄디' 유럽판매 허가임박에 급등(종합)",2017-06-26 16:03:13,0.003539823008849474,0.001377357648726596
50,[특징주] 종목명 고성장 기대감에 강세,2017-06-29 09:20:48,0.05506216696269983,0.00549822572174663
51,"[특징주]종목명, '강세'…30만원 돌파",2017-06-30 09:16:40,-0.01683501683501687,-0.0016153682668460512
52,"종목명 / 매수가 181,500원 / 비중 100%",2017-07-03 14:52:28,-0.03938356164383561,0.0011246559924318333
53,"종목명, 스위스 론자 상대로 국내특허 무효소송",2017-07-05 21:13:06,0.0017301038062282892,-0.0002261138350078129
54,"[단독]종목명, 내년 하반기 삼성바이오에피스 위탁생산 돌입",2017-07-09 17:49:18,0.001721170395869276,0.0009370179423116021
55,"[특징주]종목명, '외인 팔자'에 3%↓",2017-07-12 14:46:08,-0.032815198618307395,-0.001765434056761328
56,"[특징주]종목명, '외인 팔자'에 5%↓",2017-07-14 14:48:09,-0.032727272727272716,0.002133187114838453
57,[화제의 보고서] 삼성그룹의 미래에 투자하라 CMO업계의 금수저 ‘종목명’,2017-07-17 15:59:50,-0.02434456928838946,0.0003875885373867405
58,종목명 2분기 적자에도 '긍정적',2017-07-19 18:14:09,0.005703422053231932,0.00489730087530571
59,"종목명 2분기 영업손실 85억원…""설비유지·보수 탓""(종합)",2017-07-24 16:50:56,0.05128205128205132,-0.004744027959039054
60,"""종목명, 자회사 유럽 판매 성장…지분가치 높아질 것""-한국",2017-07-26 08:01:31,-0.005226480836236891,-0.0022090627552310282
61,"종목명, 현금성 자산비중 5년새 2.3% '뚝'…왜?",2017-07-31 13:47:22,0.007407407407407307,0.0007163590881942294
62,"[ET투자뉴스]종목명, ""fast follo…"" 매수(신규)-NH투자증권",2017-08-14 14:55:23,0.026515151515151603,0.006255096647403757
63,"[Hot-Line] ""종목명, 공장 증설…추가 수주 기대""",2017-08-18 08:29:15,0.003676470588235281,-0.0013972337832908188
64,"한국투자 ""종목명, 신약개발 청사진 제시""",2017-08-22 08:25:40,0.041894353369763104,0.004386445010615692
65,"[특징주] 종목명, 자회사 제품 유럽판매 허가에 강세",2017-08-25 09:09:04,0.0017889087656528524,0.001123780179266065
66,"종목명, 바이오의약품 위탁생산계약 의향서 체결",2017-09-06 17:59:44,-0.0017574692442882123,0.011367206174198952
67,"종목명, 종가도 30만원 뚫었다…최고가",2017-09-12 16:38:55,-0.006557377049180357,-0.0022363585523613727
68,"한투 ""종목명, 자회사 유럽출시 기대감""",2017-09-18 08:42:23,0.006125574272588086,0.013469802681419063
69,"종목명 시총, CMO 세계 1위 '론자' 제쳤다",2017-09-20 06:06:01,0.0,-0.0015935505978419418
70,"종목명, 삼성 자본력+기술력 '매수'-SK證",2017-09-26 07:52:54,0.0,-0.0025541229416502498
71,[머니S톡] 종목명 끝은 어디?,2017-09-28 05:53:41,-0.010479041916167664,0.0002401720428346632
72,"셀트리온 코스피행, 종목명 '거품' 걷힐까",2017-09-29 14:47:18,0.021180030257186067,0.008988124999675273
73,"종목명, 신고가 기록···장초반 상승세",2017-10-10 10:26:35,0.03111111111111109,0.016429559976302466
74,종목명 2공장 생산품 미국 FDA 인증,2017-10-12 19:38:34,0.029139072847682135,-0.00046060749139065216
75,"시총 '10조 클럽' 35개 사상최다, 종목명 카뱅 합류",2017-10-24 08:10:26,0.00792602377807139,0.00017667958127054462
76,"종목명, 3Q영업익 205억…'흑자전환 성공'(상보)",2017-10-25 16:28:22,0.015068493150685036,-0.004762333801404228
77,"독일 머크-종목명, 바이오의약품 제휴 연장",2017-10-30 17:33:35,0.02673796791443861,0.008593366155067894
78,"[PRNewswire] 머크와 종목명, 전략적 협력 체결",2017-11-02 10:03:21,-0.03325123152709364,-0.0039546187182654124
79,"'임원 매수' 종목명, 더 오를까?",2017-11-13 10:59:38,0.0066577896138482195,-0.004954817531916178
80,"종목명, SB3 유럽 최종 판매 허가 획득",2017-11-20 08:46:02,-0.002525252525252486,-0.002494117192625489
81,종목명 3공장 준공…2020년 본격 생산 시작,2017-11-30 15:33:53,0.0613138686131387,-0.00038774696617771554
82,"종목명, 세계 최대 규모 바이오의약품 제3공장 준공",2017-12-04 10:03:27,-0.01375515818431916,0.010608348085179742
83,종목명 ‘손영권 효과’,2017-12-05 11:25:17,-0.008368200836820106,0.0033778217204787353
84,"[특징주]종목명, 5일 만에 '강세'",2017-12-08 13:56:17,0.024316109422492405,0.0008204859569977963
85,"""종목명, 3공장 시대 성장 기대"" - 한국",2017-12-11 07:59:34,0.06379821958456966,0.0030397686688312664
86,"한투증권 ""종목명 3공장 준공, 매출성장 기대""",2017-12-12 08:32:24,-0.01673640167364021,-0.004244399144825217
87,"종목명 2공장, '유럽의약품청 제조승인' 획득",2017-12-13 10:03:29,0.028368794326241176,0.00794394514425023
88,"종목명 2공장, 유럽(EMA) 인증 획득",2017-12-15 09:04:03,0.0041551246537396835,0.005098274981763629
89,"참여연대, 종목명 분식회계 의혹규명 재촉구",2017-12-18 14:21:37,-0.024827586206896513,-7.662354195869803e-05
90,"종목명, 유럽 제약사와 451억에 생산 본계약",2017-12-21 18:25:27,-0.005730659025787954,0.004407699574126456
91,[2018년 주목받는 기업 20] 종목명 | 3공장 준공으로 생산력 세계 1위,2018-01-05 11:22:48,0.018276762402088753,0.012592971096683447
92,"종목명, 누적 수주 4조원 돌파 가시화",2018-01-08 11:01:44,0.024358974358974272,0.0063102633307419165
93,"[특징주]종목명, 사상 최고가 경신",2018-01-09 11:03:52,0.02252816020025028,-0.0012135730856913662
94,"종목명, 주요 파이프라인 의약품 성장률 상향…목표가↑-현대차",2018-01-12 08:40:49,0.04785894206549113,0.00342054588028029
95,"[특징주]종목명, 연일 신고가 경신",2018-01-15 11:20:13,0.008413461538461453,0.002928216497384728
96,[서경 스타즈 IR] '3공장 체제' 구축...종목명 매출 쑥쑥,2018-01-18 17:42:09,-0.03125,0.0017687945018269868
97,"[특징주]종목명, 40만원 회복",2018-01-23 15:03:06,0.041290322580645133,0.013784361808662826
98,"JP모건 ""종목명 '매수'…목표가 49만5천원 제시""",2018-01-26 11:14:25,0.032098765432098775,0.004890283111900873
99,"[특징주]종목명, 4공장 증설 가능성에 신고가",2018-01-30 09:51:53,-0.007963594994311762,-0.011719678580650816
100,종목명 창사 첫 흑자,2018-01-31 17:54:13,0.011402508551881407,0.0008104852721682043
101,"스위스 대통령, 종목명 방문",2018-02-08 17:12:00,-0.01597051597051602,-0.018213046439668035
102,"종목명, 3공장 첫 의약품 생산 수주 성공(종합)",2018-02-22 09:17:13,0.04235294117647048,-0.006325962019197995
103,종목명 시총 30조 돌파 원동력은?,2018-02-26 09:43:21,0.020000000000000018,0.002500441338431303
104,"종목명, POSCO 제치고 코스피 시총 5위에",2018-03-02 13:37:49,0.0344444444444445,-0.01038172907568502
105,"KB증권, 종목명 목표주가 38만원 제시",2018-03-06 08:42:11,-0.03544575725026855,0.015304814235015618
106,"종목명, 448,000원에 거래 시작",2018-03-19 09:00:51,0.0044642857142858094,-0.007594294326008111
107,"제넥신, 종목명에 임상용 항암신약 생산위탁",2018-03-21 14:51:08,-0.0032467532467532756,-0.00022130137579823295
108,"[특징주]종목명, 사상 최고가 경신…47만4000원",2018-03-22 09:54:28,0.036916395222584164,0.00444675353382773
109,"[특징주]종목명, 최고가 경신…50만원 터치",2018-03-27 09:43:12,0.01729399796541209,0.006146692156415945
110,"종목명 임원들, 40만원대에 '줄매도'",2018-03-28 15:06:01,-0.06999999999999995,-0.013364281139738532
111,"김태한 종목명 대표, 제약·바이오 업계 연봉 1위 차지",2018-04-03 13:59:05,-0.0010288065843621075,-0.0007078014787438303
112,삼성 '김기식 쇼크'…'종목명'라는 구원투수,2018-04-04 07:30:00,0.036045314109165894,-0.014071999589300832
113,"유진투자 ""종목명 1분기 실적 기대치 밑돌 듯""",2018-04-05 08:42:25,-0.001988071570576566,0.01223389794199492
114,"종목명, 셀트리온 제치고 시총 3위로 껑충",2018-04-10 11:02:02,0.03736654804270456,0.002724915627744018
115,주가·실적 고공행진에도 시름 깊어가는 종목명…분식 의혹·에피스 특혜 논란 등 ‘첩첩산중’,2018-04-16 09:35:06,-0.0052631578947368585,0.000985683476631527
116,"종목명, 위기대응시스템 글로벌 인증",2018-04-25 09:41:14,0.009493670886076,-0.006221170333530313
117,"[fn마켓워치] 종목명, 사모채 1900억원어치 발행",2018-04-27 09:28:03,0.015045135406218657,0.006769970482132681
118,"종목명 ""IFRS 기준 따라 적정하게 회계처리""",2018-05-02 11:15:07,-0.17213114754098358,-0.0038840161146347363
119,"종목명, 이재용 승계 작업에 어떤 역할을 했길래?",2018-05-03 14:16:06,-0.034653465346534684,-0.007327599353429637
120,"종목명 ""회계위반 근거 밝혀라""..금감원에 공문발송",2018-05-15 13:48:04,0.05427408412483037,-0.007095834692620984
121,"종목명 ""김태한 사장, 감리위 참석해 소명""(상보)",2018-05-16 12:29:11,0.06563706563706573,0.0005206459848914324
122,종목명 운명의 날…분식회계 의혹 해명 총력,2018-05-17 05:40:00,-0.03864734299516903,-0.004622336872487032
123,바이오젠 콜옵션 행사…종목명 분식회계 의혹 벗나,2018-05-18 10:29:07,0.02638190954773867,0.004982724272153183
124,"종목명, 2공장 FDA 추가 인증",2018-05-24 08:53:14,0.04630788485607007,-0.002386778729822958
125,"글로벌 VIP, 잇따라 종목명 방문",2018-05-29 09:05:27,0.00932400932400923,-0.008757689249342393
126,"[특징주]종목명, 증선위 불확실성에 낙폭 확대",2018-06-04 13:28:57,-0.07198228128460682,0.0036081154019402817
127,"종목명, 바이오USA서 '의약품 개발제조' 수주 나선다",2018-06-05 10:22:37,0.004773269689737569,0.002451220697898382
128,13시간 공방에도... 종목명 분식회계 논란 '여전',2018-06-08 14:28:08,0.0023809523809523725,-0.007690501582681364
129,종목명 임시위 12일 개최 왜?,2018-06-11 09:04:04,-0.002375296912114022,0.007574634892264731
130,“종목명 ‘2015년 이전 자료’도 들여다 본다”,2018-06-14 07:43:04,-0.05005820721769494,-0.018369064118312295
131,"올 증시, 사상 최고가 경신 종목은?…종목명 등313개",2018-06-18 06:00:00,-0.001225490196078427,-0.011563887684484575
132,종목명 분식회계 의혹 다음 달 중순 최종결론,2018-06-21 15:17:09,-0.011904761904761862,-0.011032499109890015
133,"종목명, 日 바이오파마 엑스포서 CDO사업 확장 나서",2018-06-27 09:20:27,0.004807692307692291,-0.0037814529184121426
134,"바이오젠 콜옵션 행사…종목명, 회계논란 새국면(종합)",2018-06-29 08:53:04,0.019559902200489088,0.005137709594241313
135,"종목명의 파장, 어디까지 갈까",2018-07-13 08:17:38,-0.06293706293706292,0.011308167983693274
136,참여연대 '회계부정 혐의' 종목명 검찰 고발,2018-07-19 11:26:19,0.02171290711700835,-0.0034147126708435893
137,"종목명, 2분기 영업익 237억원…흑자전환(종합)",2018-07-23 16:56:08,-0.00965018094089265,0.004798767782661972
138,"종목명 주가 뚝뚝 떨어져, 3달 전 최고가 '60만원'의 '반토막'",2018-07-26 09:52:20,-0.036036036036036,0.007052273747149895
139,종목명 회계 논란에서 보는 `약정사항 주석`의 중요성,2018-07-31 15:02:10,0.005390835579514919,0.0007630226126633666
140,"검찰, 종목명 공시누락 사건 배당…수사 착수",2018-08-01 22:27:26,-0.01305483028720622,-0.0159813598691273
141,"금감원 ""종목명 재감리 포기 보도 사실 아냐""",2018-08-03 10:45:09,0.03703703703703698,0.007699753932379538
142,"[특징주] 종목명, 5%대 강세…규제완화 기대",2018-08-07 14:10:23,0.0653266331658291,0.005974157883227749
143,"종목명, 대규모 투자계획에 강세",2018-08-08 16:13:48,0.013215859030837107,0.0009819939812369949
144,"“종목명 가치 평가, 증권사 리포트에 의존”",2018-08-22 17:16:20,-0.0055187637969095205,0.004077727246786456
145,"종목명, 346억 규모 의약품 위탁생산계약",2018-09-12 08:45:11,0.002143622722400762,-0.000122647602492032
146,"종목명, 바이오젠에 주식양도 내달 30일로 변경",2018-09-28 08:12:25,-0.02197802197802201,-0.005247391922843292
147,종목명 3공장 생산 돌입...세계 최대 규모 cGMP,2018-10-01 09:19:42,0.0074906367041198685,-0.0017883310692353716
148,"김태한 종목명 사장 ""4공장 건설은 내년 하반기에 결정""",2018-10-11 15:07:32,-0.04303278688524592,-0.04439546634435143
149,"금감원장 ""종목명 재감리 연말까지 마무리""",2018-10-12 17:00:52,-0.02002107481559534,-0.007738733141339216
150,"금감원, 종목명 재감리도 '고의 분식회계' 가닥",2018-10-17 21:24:56,-0.013333333333333308,-0.008858067972659533
151,"종목명, 미국 포천지 '유망기업 50'에 선정",2018-10-19 09:33:28,0.020270270270270174,0.0037005603389022035
152,"종목명, '수출입 안전관리 우수' 인증 획득",2018-10-22 09:32:00,-0.013245033112582738,0.002527501773777363
153,"종목명, 3분기 영업익 105억…전년比 48.8%↓",2018-10-23 16:37:24,-0.0359281437125748,-0.004045401264683779
154,"종목명, 14,000원(-3.48%) 내린 388,500원에 거래 시작",2018-10-25 09:00:49,-0.02857142857142858,-0.016342655691450547
155,"종목명, 11,500원(-2.86%) 내린 391,000원에 거래 마감",2018-10-25 15:30:49,-0.04859335038363166,-0.0175204886063568
156,굳은 표정의 김태한 종목명 사장,2018-10-31 13:18:54,-0.02638190954773867,0.0074453143854753545
157,종목명 ‘회계부정 의혹’ 결론 못 내…14일 재논의,2018-11-01 09:15:57,0.006451612903225712,-0.0025767383945467515
158,"종목명, 바이오젠과 자산양수도 종결...공동경영 돌입",2018-11-06 08:57:36,0.005012531328320913,0.006114917992490643
159,종목명 분식회계 결론...시장 충격은?,2018-11-14 17:07:17,0.0,0.011774305467981527
160,"종목명 상폐 심의대상 여부, 이번주 나온다",2018-11-26 09:58:11,0.0,0.01241326294703482
161,"금융위, 종목명 과징금 80억원 확정",2018-12-05 17:11:06,0.0,-0.01552370525248592
162,"종목명, 거래 재개 첫날 급등",2018-12-11 09:21:16,0.17787742899850523,-0.0003992949544147084
163,"종목명(207940) 종목알파고 분석, 외국인/기관 실시간 수급과 추가 매수 확률은?",2019-01-09 09:40:29,0.002590673575129543,0.019473917359424497
164,"종목명(207940) 종목알파고 분석, 외국인/기관 실시간 수급과 추가 매수 확률은?",2019-01-17 09:52:34,-0.03258145363408527,0.0004558002731738231
165,"[특징주]종목명, 자회사 SB3 美 판매 허가에 '강세'",2019-01-21 09:32:53,-0.007499999999999951,0.00015538346898424926
166,"종목명, 작년 매출 5천400억원·영업익 557억원(종합)",2019-01-31 16:16:12,-0.02631578947368418,-0.0006304904815347401
167,"종목명, 신입사원 보육원 봉사활동 실시",2019-03-10 09:22:06,-0.016064257028112428,0.0003088540582296684
168,"종목명 ""글로벌 바이오의약품 제조승인 22건""",2019-03-13 10:58:15,-0.008108108108108136,-0.004065502311561442
169,"[마켓인사이트]혈액암 치료제 개발 힘받나...종목명 등, 아키젠에 360억 출자",2019-03-18 11:20:01,-0.004398826979472137,0.0015531764634186818
170,[주총 2019] 국민연금 반대 뚫고 종목명 이사 재선임 등 원안 통과,2019-03-22 10:46:05,-0.028694404591104727,0.0009474516270238098
171,"종목명, 美 에이즈치료 신약 위탁생산",2019-04-02 17:54:15,0.005730659025787954,0.011983432153002127
172,"종목명, 창립 8주년 기념 임직원 사진전 개최",2019-04-10 10:47:05,0.019635343618513268,0.004892496119979883
173,"KB증권 ""종목명 2분기까지 실적부진…목표가↓""",2019-04-16 08:09:34,-0.0027210884353741083,0.002563668274695674
174,"종목명, 임직원 대상 봄축제 개최",2019-04-17 14:57:01,0.006821282401091366,-0.0012185153371458979
175,"종목명, 지아이이노베이션과 신약물질 CDO 계약",2019-05-02 11:36:28,-0.008823529411764675,0.0041568130342761744
176,"'종목명 분식회계' 의혹 증거인멸 혐의, 보안담당 직원 구속",2019-05-09 08:13:01,0.005033557046979942,-0.03044266386943484
177,'종목명 분식회계' 증거인멸 자회사 직원 구속기소,2019-05-17 14:30:01,0.013355592654423987,-0.005750326373522796
178,"美사이토다인, 종목명 방문…에이즈약 생산 협의",2019-05-31 11:25:23,0.05820105820105814,0.0014419957471758504
179,"세계 CMO 캐파 1위 종목명, 국내 바이오텍 CDO 경쟁력 강화 적극 지원",2019-06-27 15:32:03,0.015873015873015817,-0.0017335502090214394
180,"종목명, 김태한 대표 구속영장 기각 안도감에 급등",2019-07-22 13:55:05,0.008695652173912993,-0.0004870313355334055
181,"종목명(207940) 종목알파고 분석, 외국인/기관 실시간 수급과 추가 매수 확률은?",2019-07-29 09:46:13,-0.00907441016333943,-0.01780029126150484
182,"종목명, 글로벌 제약사 UCB와 세 번째 위탁생산 계약",2019-07-31 17:55:25,-0.0071428571428571175,-0.0035613261344471514
183,"종목명, 3공장에 첨단세포배양기술 적용…""생산기간 단축""",2019-08-12 09:43:27,0.07235621521335811,0.002342943620178062
184,"에이비온, 종목명와 ABN101 CDMO 계약 체결",2019-09-03 10:46:37,0.01872659176029967,-0.0017773806005847437
185,[특징주] 종목명 '증선위 제재 집행정지'에 강세,2019-09-10 09:21:00,0.012499999999999956,0.006204306254358194
186,"종목명, 회계이슈 장기화 영업 실적 타격…목표가↓-NH",2019-09-16 08:04:08,0.0017064846416381396,0.006353708916324363
187,여전한 불확실성에도 매력 높은 종목명,2019-09-17 11:35:00,0.0732538330494037,5.3392461303092276e-05
188,외국인·기관 쌍끌이에 날개 단 종목명,2019-09-20 10:19:37,0.028875379939209633,0.005369251074969883
189,"종목명, 스위스 론자 상대 '세포주' 특허무효 심판 승소",2019-10-01 11:00:12,0.05040650406504055,0.004541757484042508
190,"[국감] 유재중, “국민연금, ‘회계부정’에도 종목명 주식 매입”",2019-10-10 16:55:26,-0.0030674846625766694,0.008115751204408994
191,"종목명, 증선위 '1·2차 제재' 집행정지 확정",2019-10-16 14:18:26,0.039877300613496924,0.007088467849790003
192,"[이슈+]종목명, 본업 회복에 4공장 기대도 커져",2019-10-24 08:58:17,0.014765100671140896,0.002422256210454554
193,"종목명, 미국 바이오기업과 아토피 치료제 CMO 추가 계약",2019-11-05 11:32:37,-0.0037406483790524137,0.00582089485607673
194,"종목명, 의약품 콘퍼런스 'CPhi' 참가…""경쟁력 알려""",2019-11-06 10:07:24,0.0,0.0007047423157449106
195,"종목명, CMO 최초 ISO 27001 획득…""수주경쟁력 강화""",2019-11-14 14:00:00,0.021822849807445532,0.018718924788441393
196,"종목명, 아시아기업과 225억 규모 위탁생산 계약",2019-11-28 15:46:29,-0.013784461152882233,-0.014462444813877262
197,"SK증권 ""종목명, 내년 실적 개선 전망…목표가↑""",2019-12-04 08:41:30,-0.006345177664974666,-0.007283908172323494
198,"""종목명, 내년 실적 성장 기대감에 목표가↑""-삼성",2019-12-11 07:19:00,-0.002564102564102555,0.0036320862726406666
199,"참여연대 ""종목명 회계사기 관련 이재용 추가 고발""",2019-12-12 15:02:08,0.0025706940874035134,0.01506918591051809
200,"종목명, 523억 규모 의약품 위탁 생산계약",2019-12-26 08:46:01,-0.008393285371702586,0.0035842771590199884
201,"종목명, 상승흐름 전일대비 +5.08%... 최근 주가 상승흐름 유지",2019-12-27 10:46:18,0.038694074969770176,0.0028572471344823214
202,"종목명, 정기보수 없고 공장이전에 실적 개선…목표가↑-KB",2020-01-03 09:11:02,-0.01516919486581092,0.0005930750452882716
203,"종목명 ""2021년부터 매년 40개 CDO 수주 목표""",2020-01-13 17:09:03,-0.012485811577752526,0.004315276350379538
204,"종목명 ""올해 4월 미국 첫 진출""",2020-01-16 11:22:32,0.004602991944764101,0.007651377041939966
205,"종목명, 지난해 好실적에 시총 3위 올라",2020-01-23 09:27:08,0.06858407079646023,-0.009315301356268568
206,"[특징주] 종목명, 국내 증시 하락장에도 강세",2020-01-28 14:44:36,0.022774327122153215,-0.030902002829548803
207,"종목명, 김태한 대표이사 4연임…'장수 CEO' 등극",2020-01-30 21:26:16,-0.021212121212121238,-0.013496270949720723
208,"NH투자 ""종목명, CDMO 수요 증가…목표가↑""",2020-02-13 08:46:21,0.0,-0.0024213593238409103
209,"종목명, 에스티큐브 면역항암제 위탁개발",2020-03-03 09:24:14,0.02676659528907921,0.005812712017354782
210,"종목명, 대만 바이오벤처 치매약 위탁 개발",2020-03-17 09:34:58,-0.029069767441860517,-0.024736739075522762
211,"종목명, 김태한 사장 재선임…""올해 美 진출""",2020-03-20 14:51:55,0.17486338797814205,0.07444225452331588
212,"'종목명' 5% 이상 상승, 주가 5일 이평선 상회, 단기·중기 이평선 역배열",2020-03-23 11:01:04,0.013953488372093092,-0.05343681110846121
213,"종목명, +11.81% 상승폭 확대",2020-03-24 10:48:21,0.09174311926605494,0.0860124477925106
214,"종목명, +4.11% 상승폭 확대",2020-03-31 13:02:20,0.07111111111111112,0.021850552150841418
215,"종목명, 파멥신과 항암제 등 위탁 개발 계약",2020-04-06 09:17:04,0.02032085561497321,0.03850615858671591
216,"""종목명, 코로나 치료제 위탁생산 계약에 4공장 증설 가능성↑""",2020-04-13 08:14:04,-0.035778175313059046,-0.01877784807874172
217,"종목명, 1분기 영업이익 626억원·매출 2천72억원(종합)",2020-04-20 16:59:41,0.0229681978798586,-0.009998093169878985
218,"종목명, 485억 규모 위탁생산 의향서 체결",2020-04-22 09:03:01,0.0017271157167531026,0.00892316559470907
219,"종목명와 계약 이뮨온시아, FDA 1상 승인",2020-04-23 09:28:33,0.036206896551724155,0.00979877950838759
220,"'종목명' 52주 신고가 경신, 단기·중기 이평선 정배열로 상승세",2020-05-18 09:32:02,-0.013223140495867813,0.005100429544273588
221,종목명 3공장 '사업 연속성 국제 표준' 획득,2020-05-19 11:17:31,0.005025125628140614,0.022456133279391555
222,"종목명, 대규모 수주 소식에 상승 '사상 최고가'",2020-05-22 09:18:01,0.014778325123152802,-0.014101942725595729
223,"종목명, 연내 샌프란시스코에 R&D센터 연다",2020-05-24 06:00:00,0.02265372168284796,0.012420485418676686
224,"종목명, 'BIO Digital 2020'서 가상전시관 첫 공개",2020-06-09 10:12:39,0.01807228915662651,0.002119628308207444
225,'뉴욕증시 폭락 여파' 국내 하락세…종목명 신고가 경신,2020-06-12 12:17:18,0.07764390896921025,-0.02043384237608703
226,"종목명, 외국인 3000주 순매도… 주가 -1.33%",2020-06-18 13:33:16,-0.016990291262135915,-0.0035356805430754035
227,"종목명, 상반기에만 1조7000억 수주",2020-06-24 17:48:03,-0.004884004884004867,-0.022734057567468824
228,'-11%' 진격 멈춘 종목명… 개인이 주도 '왜?',2020-07-08 11:48:29,-0.01997336884154466,-0.0024443732195996715
229,"종목명, 에스티큐브와 CDO 추가 계약",2020-07-12 09:58:04,-0.001367989056087593,0.01665390489477958
230,"종목명, 이뮨온시아와 면역항암제 5건 위탁 개발 계약",2020-07-15 11:13:05,0.01904761904761898,0.008366775708462226
231,"종목명, 선제투자 주효...석달새 의약품 1.8조 수주",2020-07-19 10:39:02,-0.0053835800807536804,-0.001358351655305845
232,"'깜짝실적' 종목명, 과대평가 논란 '정면돌파'",2020-07-21 16:48:47,0.05333333333333323,-7.63476775010874e-05
233,고평가 논란 잠재운 종목명의 '어닝서프라이즈',2020-07-24 14:37:08,-0.02580645161290318,-0.007106791574414073
234,"종목명, 자체 세포주 '에스초이스' 공개",2020-08-05 09:03:29,0.07074829931972793,0.013987085972896773
235,종목명 '코로나19 치료제' 생산기지 부상,2020-08-06 09:16:21,-0.01143583227445999,0.013300977817339854
236,"종목명, 송도에 4공장 설립…""단일공장 세계 최대""(종합)",2020-08-11 10:31:07,0.04280155642023353,0.013530971841501982
237,시총 2위 진격한 종목명…반도체 지고 바이오 뜬다,2020-08-20 11:21:04,-0.018541409147095234,-0.036567932156985505
238,코스피 시총 2위 노리는 `종목명`…檢에 발목 잡히나,2020-08-24 15:04:05,0.026282853566958808,0.010952051790652284
239,"파멥신, 종목명와 PMC-403 위탁개발생산 계약",2020-08-25 10:53:31,-0.0060975609756097615,0.01583802284485758
240,"종목명, 파노로스 항암신약물질 위탁개발 계약",2020-09-17 09:54:26,-0.02448453608247425,-0.012213045154445767
241,"김태한 종목명 사장, 파노로스와 항암 신약 파이프라인 위탁 개발 계약",2020-09-21 13:36:12,-0.0237467018469657,-0.009538223318996009
242,"종목명, 아스트라제네카와 3850억 바이오 CMO 계약",2020-09-22 08:28:59,-0.012162162162162149,-0.023771677098995747
243,종목명가 본계약 아닌 의향서 먼저 주고받는 이유는?,2020-09-22 16:04:05,-0.035567715458276306,0.00027861817785446163
244,"종목명, 행정소송 승소…법원 ""1·2차 처분은 흡수·합병""",2020-09-24 15:38:04,0.002971768202080227,0.002679670933824818
245,"종목명, 200억원대 위탁생산 계약체결 소식에 상승세",2020-10-07 09:44:38,0.012640449438202195,0.008893038535659814
246,"[특징주] 종목명, 현직 임원 기소 소식에 하락세",2020-10-16 09:37:06,-0.024147727272727293,-0.008334681085143902
247,"바이오일레븐, 종목명와 면역항암제 CDO 계약",2020-10-19 09:14:48,-0.0014556040756914523,0.0022250242087329397
248,"종목명, 3분기 영업익 565억…전년比 139%↑",2020-10-21 17:45:13,-0.043604651162790664,-0.00666849045767004
249,[포토]빈소 찾은 김태한 종목명 사장,2020-10-27 15:27:08,0.007936507936507908,-0.005576077789119505
250,"종목명, CDO 사업 앞세워 바이오 본고장 美 진출",2020-10-29 15:13:00,0.09419152276295129,-0.007926663960811764
251,"종목명, 중국 바이오벤처 진퀀텀과 CDO 계약",2020-11-02 09:10:13,0.02346041055718473,0.01456013560059688
252,"[TF특징주] 종목명, 183억 원 상당 의약품 위탁생산 본계약에 '강세'",2020-11-04 10:12:05,0.048640915593705314,0.005978726095674514
253,종목명 분식회계 가담 혐의 삼성KPMG‧회계사 기소,2020-11-09 09:59:03,-0.020592020592020588,0.012704304158907442
254,"종목명, 릴리 항체치료제 생산 개시…두 번째 코로나 계약 (종합)",2020-11-17 09:52:34,0.02110817941952514,-0.0015257889036904837
255,"""연매출 1兆 종목명, 4공장 증설로 초격차 세계 1위 가능""",2020-11-29 13:15:41,-0.016270337922402955,-0.01599037907821632
256,"종목명·AZ 합작 아키젠, 바이오시밀러 개발 중단",2020-12-02 06:03:01,-0.003783102143757877,0.01581091468159812
257,"종목명, 신임 사장에 존림 前부사장",2020-12-08 09:55:32,-0.05909090909090908,-0.0162123411753774
258,[인사] 종목명 문형우 상무 등 4명 승진,2020-12-09 12:26:16,-0.007246376811594235,0.02019305956582662
259,"종목명 존림 신임 수장, ""향후 10년 세계 1위""",2020-12-17 01:13:10,-0.0037174721189591198,-0.0004906962579642737
260,종목명 “글로벌 바이오벨트 구축해 지속 성장할 것”,2020-12-29 11:21:29,0.041825095057034245,0.004240515411389811
261,"JP모건 헬스케어 컨퍼런스 개막…종목명, 메인트랙 발표",2021-01-12 10:24:32,-0.03309692671394804,-0.007146373723633026
262,"해수부, 바다의 '종목명' 키운다",2021-01-14 14:25:49,-0.016867469879518038,0.000520883711375264
263,"종목명, 창사 9년만에 매출 1조 돌파",2021-01-26 15:49:09,0.05860349127182052,-0.005652308105414394
264,"지엔씨에너지, 종목명에 가스터빈 비상발전기 공급",2021-01-29 09:29:51,-0.05369928400954649,-0.03025043140963124
265,[2021 유망기업] 글로벌 1위 CMO 종목명,2021-02-08 16:35:57,-0.0024875621890547706,-0.0021253827011987747
266,"유틸렉스 “면역항암제 후보물질, 종목명에 위탁 생산”",2021-03-10 09:35:37,-0.0029112081513827937,-0.006048142982261195
267,"웰마커바이오, 종목명와 면역항암제 CDMO 계약",2021-03-15 09:11:58,-0.010767160161507361,-0.0028417891310773546
268,"존림 종목명 대표 ""세포유전자·백신 사업 확대""",2021-03-19 10:57:33,-0.01939058171745156,-0.008636625749307347
269,"[뉴시스 제약·바이오 포럼]종목명, 스피드 생명 'CDO 사업'서 초격차 경쟁력 확보",2021-03-26 11:05:33,0.009749303621169991,0.01086314704592728
270,"[리포트분석] 종목명, 코로나 위기속 진짜 경쟁력은 ‘밸리데이션’",2021-03-29 08:20:36,0.03172413793103446,-0.0016343158962505155
271,"“종목명, 올 실적 1분기를 저점으로 증가할 것""",2021-04-07 09:06:40,0.01458885941644561,0.0033033480890602984
272,"""종목명, 1분기 실적보다 4공장 모멘텀 주목""",2021-04-12 08:47:00,0.01558441558441559,0.001184657502396158
273,"메드팩토, 종목명와 항체치료제 위탁개발생산 계약",2021-04-14 14:23:59,0.007653061224489832,0.004196739960068641
274,"종목명 ""2030년 글로벌 톱티어 기업으로 도약""",2021-04-21 18:05:05,-0.03361344537815125,0.0018476470247734689
275,"종목명, TG테라퓨틱스 신약 CMO 541억으로 확대",2021-04-26 09:08:07,0.008620689655172376,0.011458356943631731
276,"종목명, 1분기 영업익 743억…전년比 19% 증가",2021-04-28 18:10:02,0.011378002528444897,-0.002325938345309586
277,법정 들어가는 김태한 전 종목명 대표이사,2021-05-06 10:28:54,0.024869109947643908,0.004149437312586768
